Bioregenx (BRGX) Total Debt (2021 - 2026)

Bioregenx has reported Total Debt for 6 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt changed 0.25% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed 0.25% YoY), and the FY2025 full-year result was $2.2 million, up 92.31% from the prior year.
• Total Debt for Q1 2026 stood at $1.1 million, down from $2.2 million in the prior quarter.
• The five-year high for Total Debt was $2.2 million in Q4 2025, with the low at $200000.0 in Q4 2022.
• Average Total Debt over 5 years is $1.1 million, with a median of $1.1 million recorded in 2024.
• Year-over-year, Total Debt soared 875.61% in 2024 and plunged 38.45% in 2025.
• Tracing BRGX's Total Debt over 5 years: stood at $200000.0 in 2022, then jumped by 350.68% to $901362.0 in 2023, then increased by 26.24% to $1.1 million in 2024, then jumped by 92.31% to $2.2 million in 2025, then slumped by 48.12% to $1.1 million in 2026.
• The last three Total Debt figures came in at $1.1 million (Q1 2026), $2.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison